XYD-68298-84930

3 vaccinations 9 coded responses 23 check-ins 8 free-text entries 5 call cases

Sex: Female
Age at first dose: 41-45
ZIP prefix: 640 / MO
Registered: 2021-01-05

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-05
Registered in v-safe
2021-01-05
Dose 1 — Pfizer-BioNTech
2021-01-05
Health check-in — 0 day, dose 1
Feeling: Good · None

Adult check-in
2021-01-07
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Joint pains

Adult check-in
2021-01-09
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Fever · Chills, Headache

Adult check-in
2021-01-14
Survey response — 7 day, dose 1
MedDRA: Fatigue — Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-01-14
Report sent to call center — 7 day, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-01-21
Survey response — 14 day, dose 1
MedDRA: Fatigue, Pain — Feeling: Poor · Be unable to do your normal daily activities

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-01-27
Dose 2 — Pfizer-BioNTech
2021-01-27
Health check-in — 0 day, dose 2
Feeling: Good · None

Adult check-in
2021-01-28
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-01-29
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-01-30
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness, Nausea

Adult check-in
2021-01-31
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-02-01
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Swelling · Fatigue or tiredness

Adult check-in
2021-02-02
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-02-03
Health check-in — 7 day, dose 2
Feeling: Fair · Site: Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to do your normal daily activities

Adult check-in
2021-02-10
Survey response — 14 day, dose 2
MedDRA: Fatigue, Headache — Feeling: Fair · Be unable to do your normal daily activities

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-02-17
Health check-in — 21 day, dose 2
Feeling: Good

Adult check-in
2021-02-24
Health check-in — 28 day, dose 2
Feeling: Fair

Adult check-in
2021-03-03
Survey response — 35 day, dose 2
MedDRA: Body temperature abnormal, Fatigue, Migraine — Feeling: Poor · Be unable to do your normal daily activities

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-03-11
Survey response — 42 day, dose 2
MedDRA: Fatigue, Headache, Nausea — Feeling: Fair · Be unable to do your normal daily activities

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-04-30
Survey response — 3 month, dose 2
MedDRA: Hypoaesthesia, Impaired work ability, Limb discomfort — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-04-30
Report sent to call center — 3 month, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-06-10
Call 2 — Left Voicemail
2021-07-28
Survey response — 6 month, dose 2
MedDRA: Fatigue, Iron deficiency, Nerve compression — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

MedDRA releases: 2021-09,2024-11 · check-in answers available
2021-07-28
Report sent to call center — 6 month, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2021-08-04
Call 2 — Left Voicemail
2021-12-31
Dose 3 — Pfizer-BioNTech
2022-01-27
Survey response — 12 month, dose 2
MedDRA: Neuropathy peripheral, Pre-existing disease, Rash — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

MedDRA releases: 2024-11 · check-in answers available
2022-01-27
Report sent to call center — 12 month, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-01-28
Call 2 — Left Voicemail
2022-07-01
Health check-in — 6 month, dose 3
Feeling: Poor

Adult check-in
2023-01-02
Survey response — 12 month, dose 3
MedDRA: Hypoaesthesia, Lymphadenopathy, Office visit, Pain, Paraesthesia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional

MedDRA releases: 2024-11 · check-in answers available
2023-01-02
Report sent to call center — 12 month, dose 3
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2023-01-03
Call 1 — Left Voicemail
2023-01-03
Call 1 — Left Voicemail
2023-01-03
Call 1 — Left Voicemail
2023-01-03
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-05	Pfizer-BioNTech
2	2021-01-27	Pfizer-BioNTech
3	2021-12-31	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-01-14	priority 2/3
2021-04-30	Unsuccessful
2021-07-28	Unsuccessful
2022-01-27	Unsuccessful
2023-01-02	Unsuccessful

Free text

Release 2

Systemic reaction (other): Exhaustion

Symptoms: Extreme fatigue, body aches

Release 4

Symptoms: Headaches and exhaustion

Release 5

Symptoms: Exhaustion, and frequent migraines, inability to regulate body temperature

Symptoms: Exhaustion, headaches, nausea

Release 8

Symptoms: Problems with arm I got the injections. Numb fingers and significant issues since. Hard to write and even do my job duties.

Release 9

Symptoms: Ulnar nerve entrapment Exhaustion Iron deficiency

Release 11

Symptoms: Neuropathy in both hands and feet. Flare ups of rashes on arms

Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Office visit	·	·	✓
SD	Body temperature abnormal	✓	✓	✓
SD	Fatigue	✓	✓	✓
SD	Headache	✓	✓	✓
SD	Hypoaesthesia	✓	✓	✓
SD	Impaired work ability	✓	✓	✓
SD	Iron deficiency	✓	·	✓
SD	Limb discomfort	✓	✓	✓
SD	Lymphadenopathy	·	·	✓
SD	Migraine	✓	✓	✓
SD	Nausea	✓	✓	✓
SD	Nerve compression	✓	·	✓
SD	Neuropathy peripheral	·	·	✓
SD	Pain	✓	✓	✓
SD	Paraesthesia	·	·	✓
SD	Pre-existing disease	·	·	✓
SD	Rash	·	·	✓
SRO	Fatigue	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release